Substituted (e)-n'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
A technology of compounds and compositions, applied in the field of compounds that synthesize compounds, inhibit LSD activity, and regulate LSD activity
Active Publication Date: 2019-03-15
UNIV OF UTAH RES FOUND
View PDF4 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Further, there is a scarcity of compounds that are therapeutically effective in the treatment of cancer and other diseases associated with dysfunction of LSD1 and / or LSD2
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
preparation example Construction
[0261] 2. Drug Preparation
[0262] In one aspect, the present invention relates to a method for the manufacture of a medicament for inhibiting the activity of histone demethylase in mammals, comprising combining a therapeutically effective amount of a disclosed compound or product prepared by the disclosed method and a pharmaceutically acceptable carrier or thinner.
[0263] F. Experiment
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
Substituted (E)‑N'‑(1‑phenylethylidene)phenylhydrazide analogs or (3‑(5‑chloro‑2‑hydroxyphenyl)‑4‑methyl‑1H‑pyrazole -1-yl)(3-(morpholinosulfonyl)phenyl)methanone, derivatives thereof, and related compounds are useful as inhibitors of lysine-specific histone demethylases including LSD1 of. Synthetic methods of making the compounds; pharmaceutical compositions comprising the compounds; methods of using the compounds and compositions to treat disorders associated with LSD1 (lysine specific demethylase) dysfunction. A pharmaceutically acceptable salt, hydrate, solvate or polymorph thereof, and one or more of the following: (a) at least one agent known to increase the activity of histone demethylase; ( b) at least one agent known to reduce the activity of histone demethylases; (c) at least one agent known to treat disorders of uncontrolled cell proliferation; (d) at least one agent known to treat neurodegeneration (e) instructions for treating neurodegenerative disorders; or (f) instructions for treating disorders associated with uncontrolled cell proliferation.
Description
Background technique [0001] Over the past decade, it has become apparent that epigenetic changes, which alter the activity of genes without altering the DNA sequence, contribute to the development and progression of cancer in conjunction with genetic errors (Tsai, H.C. and Baylin, S.B. Cell Res 2011, 21(3), 502-17; and Fullgrabe, J., Kavanagh, E., and Joseph, B. Oncogene 2011). The regulation of modifications to DNA and DNA-associated proteins has become an area of intense interest, and enzymes involved in these processes have been suggested as a new class of protein targets for drug development. The major proteins associated with DNA are histones. The tails of histones host various post-translational modifications, such as phosphorylation, acetylation, methylation, and ubiquitination, and these modifications, especially acetylation and methylation of lysine residues, are important in the regulation of gene expression. plays a major role in and is often dysregulated in can...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D409/12C07D403/12C07D403/14C07D401/14A61K31/506
CPCC07D213/87C07D231/12C07D211/96C07D295/26A61P35/00A61P43/00
Inventor 哈里拉萨德·梵卡亚拉帕蒂文卡塔斯瓦米·索尔纳史蒂文·L·瓦尔奈戴维·J·贝尔斯苏尼尔·沙玛布雷特·斯蒂芬斯
Owner UNIV OF UTAH RES FOUND
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com